Biodesix Inc (BDSX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 09-2020 | 06-2020 | 03-2020 | 12-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -31,350 | -26,817 | -17,971 | -9,705 | -30,726 |
| Depreciation Amortization | 8,710 | 7,728 | 4,664 | 1,391 | 3,199 |
| Accounts receivable | -10,308 | -217 | 2,233 | 2,464 | N/A |
| Other Working Capital | -4,801 | 5,254 | 4,299 | 2,587 | -1,645 |
| Other Operating Activity | 16,383 | 1,442 | -2,065 | -1,274 | 7,446 |
| Operating Cash Flow | $-21,366 | $-12,610 | $-8,840 | $-4,537 | $-21,726 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -1,945 | -1,483 | -232 | -98 | -1,416 |
| Net Acquisitions | -750 | -750 | -500 | -250 | -456 |
| Purchase Sale Intangibles | -232 | -151 | -86 | -44 | N/A |
| Other Investing Activity | -232 | -151 | -86 | -44 | 0 |
| Investing Cash Flow | $-2,927 | $-2,384 | $-818 | $-392 | $-1,872 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 16,040 | 16,040 | 16,040 | 6,409 | N/A |
| Common Stock Issued | 73,340 | 25 | 11 | 11 | N/A |
| Other Financing Activity | -8,249 | -10 | -5 | 0 | 22,972 |
| Financing Cash Flow | $81,131 | $16,055 | $16,046 | $6,420 | $22,972 |
| Beginning Cash Position | 5,468 | 5,469 | 5,468 | 5,468 | 6,094 |
| End Cash Position | 62,306 | 6,530 | 11,856 | 6,959 | 5,468 |
| Net Cash Flow | $56,838 | $1,061 | $6,388 | $1,491 | $-626 |
| Free Cash Flow | |||||
| Operating Cash Flow | -21,366 | -12,610 | -8,840 | -4,537 | -21,726 |
| Capital Expenditure | -1,945 | -1,483 | -232 | -98 | N/A |
| Free Cash Flow | -23,311 | -14,093 | -9,072 | -4,635 | -21,726 |